<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="152967">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01819090</url>
  </required_header>
  <id_info>
    <org_study_id>2012- A01394-39</org_study_id>
    <nct_id>NCT01819090</nct_id>
  </id_info>
  <brief_title>Optimizing Communication During Ventilation</brief_title>
  <acronym>PHONOVNI</acronym>
  <official_title>Optimizing Communication During Nasal Mechanical Ventilation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre d'Investigation Clinique et Technologique 805</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre d'Investigation Clinique et Technologique 805</source>
  <oversight_info>
    <authority>France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Mechanical ventilation is one of the only treatment that has improved survival of patients
      with neuromuscular respiratory failure. As disease progresses, some patients may require
      longer ventilation period.  Non invasive mechanical ventilation is the preferred method of
      ventilation but it may interfere with speech and communication of patients who require
      ventilation throughout the day.  The investigators are evaluating the effect on speech and
      communication of a ventilation device which allows patients to momentarily and voluntarily
      withhold ventilation if they want to speak. This should allow the patients to have a more
      fluid speech.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>April 2013</start_date>
  <completion_date type="Anticipated">March 2014</completion_date>
  <primary_completion_date type="Anticipated">March 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Supportive Care</study_design>
  <primary_outcome>
    <measure>Impact of patient's ventilation control on speech efficiency</measure>
    <time_frame>1 hour 30 min</time_frame>
    <safety_issue>No</safety_issue>
    <description>Speech efficiency will be evaluated while using a ventilator which allows the patient to constantly control when he wants to be ventilated Speech evaluation is based on speech rhythm and text reading duration</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Patient ventilator synchronisation during speech</measure>
    <time_frame>1hour 30 min</time_frame>
    <safety_issue>No</safety_issue>
    <description>Evaluated with the variation of respiratory frequency during speech, the number of auto-triggered ventilation cycles during speech.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>User friendliness of the ventilator during speech</measure>
    <time_frame>1hour 30 min</time_frame>
    <safety_issue>No</safety_issue>
    <description>evaluation of user friendliness by the patient using a visual analogical score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Respiratory comfort during speech</measure>
    <time_frame>1hour 30 min</time_frame>
    <safety_issue>No</safety_issue>
    <description>evaluation of user friendliness by the patient using a visual analogical score and the Borg score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Speech comfort during ventilation</measure>
    <time_frame>1hour 30 min</time_frame>
    <safety_issue>No</safety_issue>
    <description>evaluation of speech comfort during ventilation by the patient using a visual analogical score</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Neuromuscular Disorder</condition>
  <condition>Respiratory Failure</condition>
  <arm_group>
    <arm_group_label>No ventilation switch control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Neuromuscular patients non invasively ventilated in a stable state at the time of the study testing an usual (with no ventilation switch control) Elysee 150 ventilator while speaking</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ventilation switch control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Neuromuscular patients non invasively ventilated in a stable state at the time of the study testing an Elysee 150 ventilator with a ventilation switch control allowing them to control ventilation while speaking</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Elysee 150 ventilator</intervention_name>
    <arm_group_label>No ventilation switch control</arm_group_label>
    <other_name>Elysee 150 - Resmed</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Elysee 150 ventilator with a ventilation switch control</intervention_name>
    <arm_group_label>Ventilation switch control</arm_group_label>
    <other_name>Elysee 150 ventilator - Resmed - with a ventilation switch control</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient with restrictive respiratory failure secondary to a neuromuscular disorder,
             without any bulbar involvement.

          -  Age greater than or equal to 18.

          -  Hospitalization in Home Ventilation Unit of the intensive care department of R.
             Poincaré Hospital.

          -  Non invasive mechanical ventilation for a duration equal or above 14h per day.

          -  Patient in a steady state at the time of the study

          -  written informed consent

        Exclusion Criteria:

          -  patient's refusal to participate to the study

          -  Inability to read the selected text

          -  Inability to use the ventilator switch

          -  Inability to cooperate

          -  Hemodynamic instability

          -  Acute respiratory failure

          -  No affiliation to social security
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Helene PRIGENT, MDPHD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hôpital RAYMOND POINCARE</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Helene PRIGENT, MDPHD</last_name>
    <phone>13347107911</phone>
    <email>helene.prigent@rpc.aphp.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>FREDERIC LOFASO, MDPHD</last_name>
    <phone>13347107940</phone>
    <email>f.lofaso@rpc.aphp.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hopital Raymond Poincare</name>
      <address>
        <city>Garches</city>
        <zip>92380</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Helene PRIGENT, MDPHD</last_name>
      <phone>33147107911</phone>
      <email>helene.prigent@rpc.aphp.fr</email>
    </contact>
    <contact_backup>
      <last_name>Sandra POTTIER, CRA</last_name>
      <phone>33147104469</phone>
      <email>sandra.pottier@rpc.aphp.fr</email>
    </contact_backup>
    <investigator>
      <last_name>David ORLIKOWSKI, MDPHD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Frederic LOFASO, MDPHD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>April 2013</verification_date>
  <lastchanged_date>April 3, 2013</lastchanged_date>
  <firstreceived_date>March 7, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Centre d'Investigation Clinique et Technologique 805</investigator_affiliation>
    <investigator_full_name>Helene Prigent</investigator_full_name>
    <investigator_title>MDPHD</investigator_title>
  </responsible_party>
  <keyword>Neuromuscular disorder</keyword>
  <keyword>Mechanical ventilation</keyword>
  <keyword>Speech</keyword>
  <keyword>Respiratory failure</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Neuromuscular Diseases</mesh_term>
    <mesh_term>Respiratory Insufficiency</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
